Revolutionising Healthcare Cystic fibrosis (CF) is a genetic disease that affects around 11,000 people in the UK, and over 160,000 globally. One of the most important bugs that causes this is Pseudomonas aeruginosa – a bacterium that is present everywhere but rarely...
COST Action Biofilm RegulatoryToolBox NBIC are pleased to be co-leading the EU COST Action CA23152: RegulatoryToolBox ‘Building Consensus on Biofilm Regulatory Decision Making’, which officially launched on 26 October 2024 with a meeting in Brussels, attended by...
National Biofilms Innovation Centre Annual Report 2024 The National Biofilms Innovation Centre (NBIC) Annual Report 2024 is now available to download. This report covers our key achievements to date and our future plans. Download Annual Report 2024 Foreword – A...
Report Calls for Initiative to Establish a World-leading UK Microbiome Biobank We’re pleased to announce the release of a new NBIC-facilitated report from CABI Agriculture and Bioscience. The report calls for a “highly ambitious enterprise” to create a microbiome...
Innovative Businesses Secure Funding After Completing LYVA Labs’ Microbials Accelerator Programme Nine innovative businesses are celebrating receiving £857,000 in funding, from the Innovate UK Biomedical Catalyst feasibility grant, after completing LYVA Labs’...
